ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,986Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 586

$541K Total Retail Price of All Prescriptions

Rank: 18 out of 586

289 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 289 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 289 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,646 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 326 299 1 1
LEVOTHYROXINE SODIUM 299 262 2 2
OMEPRAZOLE 240 198 3 3
LISINOPRIL 220 194 4 4
METFORMIN HCL 202 186 5 6
HYDROCODONE-ACETAMINOPHEN 201 173 S3 6 5
METOPROLOL SUCCINATE 192 188 7 19
POTASSIUM CHLORIDE 187 163 8 14
TRAMADOL HCL 178 142 9 15
FUROSEMIDE 164 135 10 9
CYMBALTA 149 78 11 29
WARFARIN SODIUM 147 142 12 13
GABAPENTIN 137 91 13 11
DONEPEZIL HCL 129 123 14 40
AMLODIPINE BESYLATE 126 119 15 7
NAMENDA 120 118 16 54
ZOLPIDEM TARTRATE 116 81 17 8
TRAZODONE HCL 115 71 18 20
ALENDRONATE SODIUM 110 90 19 23
CITALOPRAM HBR 108 87 20 12
TAMSULOSIN HCL 107 102 21 27
TRIAMTERENE-HCTZ 95 89 22 53
LOSARTAN POTASSIUM 83 77 23 18
ALLOPURINOL 80 80 24 35
GLIMEPIRIDE 76 72 25 38
DIGOXIN 72 72 26 96
LANTUS 70 63 27 33
BENAZEPRIL HCL 68 65 28 52
JANUVIA 67 55 29 74
METFORMIN HCL ER 67 59 29 37
ATORVASTATIN CALCIUM 67 52 29 17
BUMETANIDE 65 65 32 169
FLUTICASONE PROPIONATE 62 57 33 28
FENOFIBRATE 62 62 33 39
CRESTOR 60 44 35 42
NEXIUM 60 48 35 51
PRAMIPEXOLE DIHYDROCHLORIDE 59 59 37 143
LYRICA 56 52 38 87
ACTOS 55 51 39 138
BISOPROLOL-HYDROCHLOROTHIAZIDE 55 37 39 91
BISOPROLOL FUMARATE 53 47 41 232
HYDROCHLOROTHIAZIDE 52 52 42 10
FLUOXETINE HCL 51 51 43 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.